EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antimicrobial‐Releasing Implant Substrates for Combating Oral Biofilms: An In Vitro Study

Nur Hidayatul Nazirah Kamarudin, Lars Vanmunster, Brecht Van Hooreweder, Kenneth Siemons iD, Kristel Bernaerts, Wim Teughels, Annabel Braem iD, Naiera Zayed iD

Clinical Oral Implants Research · 2026

DOI: 10.1111/clr.70067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oral Implants Research, 2026. Verfasst von Nur Hidayatul Nazirah Kamarudin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Engineering, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Biofilms, Chlorhexidine, Dental Implants, Peri-Implantitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KU Leuven, European Union's Horizon Europe program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Peri‐implantitis, a biofilm‐associated inflammatory disease, significantly threatens dental implant longevity. Current treatments face limitations due to biofilm robustness. This study evaluates the efficacy of antimicrobial‐releasing titanium‐silica (Ti/SiO 2 ) composite implant systems against multispecies oral biofilms, aiming to advance innovative localized and targeted peri‐implantitis prevention and management strategies. Materials and Methods Ti/SiO 2 inserts were engineered with macroporous Ti6Al4V discs produced by additive manufacturing (AM) and a sol–gel‐derived mesoporous SiO 2 barrier for controlled antimicrobial release across the discs. Chlorhexidine (CHX), as the gold standard antimicrobial agent in dental practice, was tested for its release efficacy using either a laboratory‐prepared chlorhexidine diacetate solution (CHX‐DA) or the commercial formulation Corsodyl. Phosphate‐buffered saline (PBS) and Brain Heart Infusion‐2 (BHI‐2) medium served as control solutions. After establishing the CHX‐DA release profile, multispecies biofilms were grown on the inserts. The antimicrobial efficacy of the release systems was assessed via viability‐qPCR, scanning electron microscopy (SEM), and metabolic acid profiling. All experiments were conducted four times.

Results

A mean pore diameter of 5.6 nm was observed for the discs, resulting in a steady drug release rate (≈0.00077 mmol/L CHX‐DA/day). The antimicrobial‐fed inserts showed less biofilm formation, with ≥ 2 log 10 reductions in viable bacteria compared to controls. CHX‐DA and Corsodyl showed effective suppression of pathogenic bacteria and reductions in metabolic acid production. SEM analysis revealed morphological changes in bacterial cells on treated surfaces.

Conclusion

Antimicrobial‐releasing Ti/SiO 2 implant discs demonstrated sustained efficacy in biofilm prevention and treatment, indicating their feasibility as a future strategy for peri‐implantitis management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsChlorhexidineDental ImplantsPeri-ImplantitisAnti-Infective AgentsIn Vitro TechniquesTitaniumSilicon DioxideMicroscopy, Electron, ScanningHumansAlloysAnti-Infective Agents, Local

Stichwörter der Autor:innen

anti‐bacterial agentsbiofilmsdental implantsdrug delivery systemsperi‐implantitis

Substanzen

ChlorhexidineDental ImplantsTitaniumSilicon DioxideAnti-Infective Agentstitanium alloy (TiAl6V4)AlloysAnti-Infective Agents, Local

Autor:innen und Institutionen

  • Department of Materials Engineering, KU Leuven, Leuven, Belgium.
  • Department of Chemical and Process Engineering, Faculty of Engineering and Built Environment, Universiti Kebangsaan, Bangi, Malaysia.
  • Department of Mechanical Engineering, KU Leuven, Leuven, Belgium.
  • FlandersMake at KU Leuven, Leuven, Belgium.
  • Chemical and Biochemical Reactor Engineering and Safety, Department of Chemical Engineering, Leuven Chem&Tech, KU Leuven, Leuven, Belgium.
  • Department of Oral Health Sciences, KU Leuven, Leuven, Belgium.

ORCID-Profile: Kenneth Siemons, Annabel Braem, Naiera Zayed

Förderung

  • KU Leuven
  • European Union's Horizon Europe program

Zitieren

APA

Kamarudin, N. H. N., Vanmunster, L., Van Hooreweder, B., Siemons, K., Bernaerts, K., Teughels, W., Braem, A., & Zayed, N. (2026). Antimicrobial‐Releasing Implant Substrates for Combating Oral Biofilms: An In Vitro Study. Clinical Oral Implants Research. https://doi.org/10.1111/clr.70067

Vancouver

Kamarudin NHN, Vanmunster L, Van Hooreweder B, Siemons K, Bernaerts K, Teughels W, et al. Antimicrobial‐Releasing Implant Substrates for Combating Oral Biofilms: An In Vitro Study. Clinical Oral Implants Research. 2026. doi:10.1111/clr.70067

BibTeX
@article{Kamarudin2026,
  author = {Kamarudin, Nur Hidayatul Nazirah and Vanmunster, Lars and Van Hooreweder, Brecht and Siemons, Kenneth and Bernaerts, Kristel and Teughels, Wim and Braem, Annabel and Zayed, Naiera},
  title = {Antimicrobial‐Releasing Implant Substrates for Combating Oral Biofilms: An In Vitro Study},
  journal = {Clinical Oral Implants Research},
  year = {2026},
  doi = {10.1111/clr.70067}
}
Kostenlos starten →